Larry Dillaha

Directeur Général chez Melt Pharmaceuticals, Inc.

Profil

Larry M.
Dillaha currently works at Melt Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2021, New Haven Pharmaceuticals, Inc., as Chief Medical Officer & Executive VP-Operations from 2014, and Nutriband, Inc., as Chief Medical Officer from 2018.
Dr. Dillaha also formerly worked at Repros Therapeutics, Inc., as President, Chief Executive Officer & Director from 2017 to 2018, Cavtherx, Inc., as Chief Executive Officer & Director from 2016 to 2017, Baptist Hospital (Tennessee), as Medical Director from 2000 to 2002, Sanofi-Aventis U.S.
LLC, as Medical Director in 2006, Sanofi-Synthelabo, Inc., as Medical Director-Cardiovascular from 2002 to 2006, Shionogi Pharma, Inc., as Chief Medical Officer from 2006 to 2010, Shionogi & Co., Ltd., as Chief Medical Officer & Executive Vice President, Harrow, Inc., as Chief Medical Officer, and INSYS Therapeutics, Inc., as Chief Medical Officer from 2011 to 2014.
Dr. Dillaha received his undergraduate degree and doctorate degree from the University of Tennessee.

Postes actifs de Larry Dillaha

Sociétés	Poste	Début
New Haven Pharmaceuticals, Inc.	Directeur des opérations	-
Melt Pharmaceuticals, Inc.	Directeur Général	01/06/2021

Anciens postes connus de Larry Dillaha

Sociétés	Poste	Fin
HARROW, INC.	Directeur Technique/Scientifique/R&D	01/01/2021
REPROS THERAPEUTICS INC	Directeur Général	01/02/2018
Cavtherx, Inc.	Directeur Général	01/02/2017
INSYS THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	11/05/2014
Shionogi Pharma, Inc.	Directeur Technique/Scientifique/R&D	01/03/2010